Kalvista Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Kalvista Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kalvista Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kalvista Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $253k | 21k | 12.18 |
| 2025-03-31 | $4.6M | 403k | 11.54 |
| 2024-12-31 | $180k | 21k | 8.47 |
| 2024-09-30 | $262k | 23k | 11.58 |
| 2024-06-30 | $247k | 21k | 11.78 |
| 2024-03-31 | $1.1M | 91k | 11.86 |
| 2023-12-31 | $328k | 27k | 12.26 |
| 2023-09-30 | $2.6M | 271k | 9.63 |
| 2023-06-30 | $2.6M | 290k | 9.00 |
| 2023-03-31 | $2.5M | 316k | 7.86 |
| 2022-12-31 | $2.2M | 327k | 6.78 |
| 2022-06-30 | $1.4M | 144k | 9.86 |
| 2022-03-31 | $198k | 13k | 14.72 |
| 2021-12-31 | $142k | 11k | 13.23 |
| 2021-03-31 | $220k | 8.3k | 26.42 |
| 2020-12-31 | $677k | 36k | 19.03 |
| 2020-09-30 | $293k | 23k | 12.59 |
| 2020-06-30 | $377k | 31k | 12.10 |
| 2020-03-31 | $456k | 59k | 7.69 |
| 2019-12-31 | $340k | 19k | 17.74 |
| 2019-09-30 | $44k | 3.8k | 11.50 |
| 2019-06-30 | $803k | 37k | 21.52 |
| 2019-03-31 | $1.8M | 62k | 28.62 |
| 2018-12-31 | $727k | 37k | 19.76 |
| 2018-09-30 | $124k | 5.6k | 22.10 |
| 2018-06-30 | $59k | 7.3k | 8.12 |
| 2018-03-31 | $199k | 21k | 9.50 |
| 2017-12-31 | $283k | 29k | 9.73 |